AcelRx Pharmaceuticals

SCOPE
Manufacture a novel preprogrammed drug delivery device that administers a sublingual dose of sufentanil. The device provides an alternative to IV patient-controlled analgesia in the hospital.
OUTCOME
Successful production transfer. AcelRx Pharmaceuticals was acquired by Talphera.

Meet Our Team

Get in touch with us today to see how we can help you achieve your goals.